Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies GOLDMAN SACHS GROUP INC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Colin Walsh - $27.32M in ATTO purchases and sales in the last 12 months
- Redmile Group, LLC - $10.20M in ATTO purchases and sales in the last 12 months
- Frazier Life Sciences XI, L.P. - $10.00M in ATTO purchases and sales in the last 12 months
- venBio Global Strategic Fund IV, L.P. - $6.50M in ATTO purchases and sales in the last 12 months
- Sanofi - $5.10M in ATTO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is GOLDMAN SACHS GROUP INC?
GOLDMAN SACHS GROUP INC is a corporate entity of Attovia Therapeutics, Inc. (ATTO). InsiderAlpha holds 10 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has GOLDMAN SACHS GROUP INC submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has GOLDMAN SACHS GROUP INC been buying or selling stock?
Recorded transactions: 60 open-market purchases ($26.26M) and 73 open-market sales ($19.57M) across all tracked filings.
